FAQs on Multiple Myeloma: Diagnosis & Prognosis

Mary DeRome, Senior Director of Medical Communications and Education at the Multiple Myeloma Research Foundation, gets answers to frequently asked questions about multiple myeloma diagnosis, prognosis, and initial treatment from the University of Chicago’s Dr. Benjamin Derman (Assistant Professor of Medicine) and Sarah Major (physician assistant), as well as myeloma patient Julia Grosch.
Dr. Derman, Ms. Major, and Ms. Grosch provide insights on a range of topics relating to newly diagnosed multiple myeloma, such as...
00:35 Precursor conditions
08:37 MM diagnosis and prognosis
21:54 Initial treatment and response
52:00 Side effects and other issues
This session is supported by Adaptive, Bristol Myers Squibb, Genentech, GSK, Janssen, Karyopharm, and Takeda.
If you have additional questions, call our MMRF Patient Navigation Center at 1-888-841-6673.

[@gracestrand2240]

I haven’t heard anyone speak to the quality of life during the chemo treatment phases. Intimacy , touch and sexuality - as a retired medical professional, I ve yet to hear the profound affects of touch, snuggling and sexual activity that will , possibly add the curative hormone changes, like oxytocin , that will likely influence efficacy of treatment protocols. I know there is not a patient or member of a treatment team that does not grasp the value of touch, hugs and more. Tell us all how that can be an adjunct to all of the pharmacological treatments available to each patient.
Warmly,
Chris

[@amyjenkins9187]

What are some labs that would be a red flag fot this

[@normanhockett3972]

I had a stem cell transplant, MM caused by agent orange. I'm on REVLIMID still. Stem cell was done June 2020. I'm not in remission.
What can I expect

[@janemccourt5022]

I got MGUS diagnosed, IgA, after Glandular Fever, Epstein Barr was diagnosed at the age of 36. I am certain this caused it. xx